Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Smoking

Ban on tobacco advertising to protect children and young people

    • General Internal Medicine
    • News
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
  • 2 minute read

More than a quarter of all Swiss people smoke. Although most people are aware that tobacco use can be associated with major limitations to their health. But quitting smoking is not that easy. Therefore, the measures to prevent already children and adolescents from a possible addiction are intensifying. One initiative called for a ban on tobacco advertising.

Smoking is dangerous. Every child knows that. It is a risk factor for cardiovascular disease, chronic respiratory disease, and various cancers. More than one in seven deaths is attributable to diseases caused by smoking. Passive smoking also harms health to a similar extent as smoking itself. Smoking is the greatest preventable health risk in Western industrialized nations. In Switzerland, 9500 people die each year from the consequences of tobacco consumption. Despite a trend reversal toward greater health awareness, tobacco use remains at a high level of nearly 2 million smokers [1,2]. These figures are expected to adjust downward in the future. Therefore, measures are taken to warn children and young people not only about the dangers of the addictive substance. They should not be made aware of it in the first place. On February 13, the popular initiative “Yes to the protection of children and adolescents from tobacco advertising (children and adolescents without tobacco advertising)” was therefore adopted. The initiative demands that all tobacco advertising that reaches children and adolescents be banned. A maximum period of three years is provided for this [3]. Advertising for tobacco products is permitted in Switzerland under restrictions. However, advertising aimed specifically at minors is prohibited. Neither is it permitted to give promotional gifts to minors or to distribute cigarettes free of charge. Tobacco advertising is generally prohibited on radio and television. And in the majority of cantons, there is also a ban on tobacco advertising on billboards and in cinemas, as well as on sponsoring events. On the basis of the initiative, only advertising such as promotional e-mails, brochures or targeted advertising on the Internet to which minors do not have access is now possible. The initiative goes too far for the Federal Council and Parliament. However, since this was adopted by a majority, statutory implementing provisions must now be adopted by Feb. 13, 2025.

 

Literature:

  1. www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/determinanten/tabak.html (last accessed on 30.01.2022)
  2. www.bag.admin.ch/bag/de/home/gesund-leben/sucht-und-gesundheit/tabak.html (last accessed on 11.03.2022)
  3. www.bag.admin.ch/bag/de/home/strategie-und-politik/politische-auftraege-und-aktionsplaene/politische-auftraege-zur-tabakpraevention/tabakpolitik-schweiz/volksinitiative-kinder-ohne-tabakwerbung.html (last accessed on 11.03.2022)

 

CARDIOVASC 2022; 21(1): 36
InFo PNEUMOLOGY & ALLERGOLOGY 2022; 4(2): 29.
HAUSARZT PRAXIS 2022; 17(7): 19

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • practice management
  • Smoking
  • Tobacco
  • Tobacco advertising
Previous Article
  • Thyroid Cancer

System therapy: Current developments

  • Education
  • Endocrinology and Diabetology
  • Oncology
  • RX
  • Studies
View Post
Next Article
  • Cardiac Surgery

New developments to reduce surgical trauma

  • Anesthesiology
  • Cardiology
  • Congress Reports
  • Psychiatry and psychotherapy
  • RX
  • Surgery
View Post
You May Also Like
View Post
  • 4 min
  • Case Study: Secondary Pseudohypoaldosteronism

Severe electrolyte imbalances and nonspecific symptoms in an infant

    • RX
    • Cases
    • Education
    • General Internal Medicine
    • Nephrology
    • Pediatrics
    • Urology
View Post
  • 4 min
  • CKD and High Blood Pressure

Keeping an Eye on Bidirectional Interactions

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 20 min
  • Molecular Classification, FIGO 2023, and Chemoimmunotherapy

Endometrial carcinoma

    • RX
    • CME continuing education
    • Gynecology
    • Oncology
    • Studies
View Post
  • 4 min
  • Psoriatic Arthritis

Older patients at risk for tachyarrhythmias

    • RX
    • Cardiology
    • Dermatology and venereology
    • Education
    • General Internal Medicine
    • Geriatrics
    • Pharmacology and toxicology
    • Rheumatology
    • Studies
View Post
  • 3 min
  • Genetic Kidney Disease: DOUBLE PROTECT Alport

The SGLT-2 inhibitor dapagliflozin as an add-on to RAS blockade

    • RX
    • Education
    • General Internal Medicine
    • Genetics
    • Nephrology
    • Studies
View Post
  • 4 min
  • Case Study: Cystic Fibrosis in Adults

Recurrent Pneumonia as a Manifestation of Cystic Fibrosis

    • RX
    • Education
    • Infectiology
    • Pneumology
View Post
  • 5 min
  • Long COVID/Fatigue Clinic

An Innovative Approach: Neuroplasticity and Predictive Processing

    • RX
    • Congress Reports
    • General Internal Medicine
    • Infectiology
    • Neurology
    • Physical medicine and rehabilitation
    • Pneumology
    • Psychiatry and psychotherapy
View Post
  • 6 min
  • T-cell lymphomas

Diagnostic Challenges and New Treatment Options

    • RX
    • Education
    • Hematology
    • Oncology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Endometrial carcinoma
  • 2
    Clinical Presentation, Diagnosis, and Treatment of DSPN
  • 3
    Why is it so hard to lose weight?
  • 4
    Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
  • 5
    Functional limb preservation between infection control, vascular medicine and resurfacing

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.